// App-Quantinova.ai

e13534 : Risk of serious anemia with mTOR inhibitors in cancer patients: A meta-analysis of randomized controlled trials.

Researchers

Presenter

  • Anu Radha Neerukonda

Principal Investigators

  • Shiney Koshy

  • Shenhong Wu

Medical Centers

  • Stony Brook University School of Medicine, Stony Brook, NY

  • Stony Brook University, Stony Brook, NY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Anemia

  • Solid malignancies

Biomarkers

  • Serine/threonine-protein kinase mTOR

Drug/Treatment

  • Temsirolimus

  • Everolimus

Outcome

  • Negative

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved